On May 12, 2017, former professional baseball player Doug DeCinces and associate David Parker were convicted of insider trading after a two-month trial in the Central District of California. The government argued that DeCinces’s neighbor, James V. Mazzo, CEO of Advanced Medical Optics, Inc. (NYSE: EYE), told DeCinces that EYE was going to be acquired by Abbott Laboratories. According to the prosecution, DeCinces then liquidated his stock portfolio, suffering $80,000 in losses, in order to obtain $160,000, which he used to purchase EYE stock. DeCinces also passed information about the pending acquisition to Parker, who also purchased EYE stock. After selling their EYE stock after Abbott Laboratories’ tender offer for the company was publicly announced, Parker and DeCinces, respectively, realized $350,000 and $1.3 million in profits. DeCinces was convicted of 14 counts of insider trading and Parker was convicted of 3 counts of insider trading. The jury could not reach a verdict with regard to an additional 18 counts of insider trading against DeCinces, counts on which the judge therefore declared a mistrial. Mazzo was also charged with 13 counts of insider trading and 13 counts of insider trading in the context of a tender offer, but the jury also could not reach a verdict on these counts, and the judge declared a mistrial as to Mazzo’s charges as well. United States v. DeCinces, 8:12-cr-00269 (C.D. Cal.).